BNP Paribas Financial Markets’s AC Immune ACIU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.42K Buy
2,699
+289
+12% +$796 ﹤0.01% 5432
2026
Q1
$6.63K Sell
2,410
-70
-3% -$217 ﹤0.01% 5285
2025
Q4
$7.79K Sell
2,480
-323
-12% -$1.02K ﹤0.01% 5203
2025
Q3
$8.1K Buy
2,803
+1,476
+111% +$3.33K ﹤0.01% 5043
2025
Q2
$2.69K Buy
1,327
+116
+10% +$202 ﹤0.01% 5022
2025
Q1
$2.27K Sell
1,211
-792
-40% -$2K ﹤0.01% 4968
2024
Q4
$5.41K Sell
2,003
-262
-12% -$819 ﹤0.01% 4925
2024
Q3
$8.56K Sell
2,265
-1,299
-36% -$4.54K ﹤0.01% 3807
2024
Q2
$14.2K Sell
3,564
-7,528
-68% -$24.9K ﹤0.01% 3685
2024
Q1
$32.8K Buy
11,092
+8,423
+316% +$30.2K ﹤0.01% 3609
2023
Q4
$13.3K Buy
+2,669
New +$8.58K ﹤0.01% 3691
2023
Q1
Sell
-901
Closed -$1.84K 3843
2022
Q4
$1.84K Buy
901
+108
+14% +$278 ﹤0.01% 3747
2022
Q3
$2.51K Sell
793
-2,076
-72% -$6.54K ﹤0.01% 4321
2022
Q2
$10.4K Buy
+2,869
New +$9.81K ﹤0.01% 3746
2021
Q4
Sell
-13,642
Closed -$91.5K 4200
2021
Q3
$91.5K Buy
+13,642
New +$97.7K ﹤0.01% 3307

Other funds holding ACIU

BNP Paribas Financial Markets's ACIU Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its AC Immune (ACIU) stake by 12% in Q2 2026, buying an estimated $796 and bringing the position to 2,699 shares worth $6.42K. The position accounts for ﹤0.01% of the portfolio, ranked #5432.

BNP Paribas Financial Markets first reported a position in ACIU in Q3 2021 and has held it in 15 quarters since. The position peaked at $91.5K in Q3 2021. 34 funds tracked by Wall St. Rank hold ACIU as of Q2 2026.

  • BNP Paribas Financial Markets held 2,699 shares of AC Immune worth $6.42K as of Q2 2026.
  • BNP Paribas Financial Markets bought 289 AC Immune shares in Q2 2026, an estimated $796.
  • AC Immune made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5432 holding.
  • BNP Paribas Financial Markets first reported a position in AC Immune in Q3 2021 and has held it in 15 quarters since.
  • BNP Paribas Financial Markets's AC Immune position peaked at $91.5K in Q3 2021.
  • 34 funds tracked by Wall St. Rank held AC Immune as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.